Prediction of Tacrolimus Drug Dosing and Metabolism based on CYP3A5 Polymorphism in Indian Renal Transplant Recipients

被引：0
|
作者：
Patel, Mohan [1 ]
Goswami, Jitendra [3 ]
Balwani, Manish [4 ]
Gumber, Manoj [2 ]
机构：
[1] Apollo Hosp, Dept Nephrol & Transplantat, Nasik, India
[2] Apollo Hosp, Dept Nephrol & Transplantat, Ahmadabad, Gujarat, India
[3] Manipal Hosp, Dept Nephrol & Transplantat, Jaipur, Rajasthan, India
[4] Jawaharlal Nehru Med Coll, Dept Nephrol & Transplantat, Sawangi, Wardha, India
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000542683.60190.23
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C391.2
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [21] CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients
    Htun, Y. Y.
    Swe, H. K.
    Saw, T. M.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (04) : 1034 - 1040
  • [22] Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre
    Cheng, Y.
    Li, H.
    Meng, Y.
    Liu, H.
    Yang, L.
    Xu, T.
    Yu, J.
    Zhao, N.
    Liu, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 : 16 - 22
  • [23] Donor CYP3A5 Gene Polymorphism Alone Cannot Predict Tacrolimus Intrarenal Concentration in Renal Transplant Recipients
    Zhang, Mengyu
    Tajima, Soichiro
    Shigematsu, Tomohiro
    Fu, Rao
    Noguchi, Hiroshi
    Kaku, Keizo
    Tsuchimoto, Akihiro
    Okabe, Yasuhiro
    Egashira, Nobuaki
    Masuda, Satohiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [24] Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Cardiac Transplant Recipients
    Wu, Yanting
    Eadon, Michael T.
    Schenkelberg, Laurie
    Rao, Roopa A.
    Skaar, Todd C.
    Tillman, Emma M.
    Shugg, Tyler A.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 20 - 20
  • [25] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618
  • [26] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618
  • [27] Effect of CYP3A5*1/*3 Polymorphism on Blood Pressure in Renal Transplant Recipients
    Torio, A.
    Auyanet, I.
    Montes-Ares, O.
    Guerra, R. M.
    Fernandez, E. J.
    Perez, M. A.
    Ramirez, A.
    Checa, M. D.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2596 - 2598
  • [28] CYP3A5 polymorphism in kidney transplantation: individualizing tacrolimus dosing.
    Pasari, Amit S.
    Balwani, Manish R.
    Bawankule, Charulata
    Sejpal, Kapil
    Gurjar, Prasad
    Kashiv, Pranjal
    Dubey, Shubham
    Malde, Sunny
    Gupta, Sushrut
    Pawar, Twinkle
    TRANSPLANTATION, 2024, 108 (9S)
  • [29] CYP3A5 polymorphism and tacrolimus pharmacokinetic/pharmacodynamic interactions in young kidney transplant recipients.
    Ghio, L.
    Ferraresso, M.
    Tirelli, S.
    Grillo, P.
    Belingheri, M.
    Martina, V.
    Torresani, E.
    Berardinelli, L.
    Edefonti, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 577 - 577
  • [30] Influence of CYP3A5 polymorphism on tacrolimus trough concentrations and acute rejection or chronic allograft nephropathy in renal transplant recipients
    Satoh, Shigeru
    Saito, Mitsuru
    Inoue, Takamitsu
    Kagaya, Hideaki
    Miura, Masatomo
    Inoue, Kazuyuki
    Habuchi, Tomonori
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 445 - 446
12345